vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and F5, Inc. (FFIV). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $811.7M, roughly 1.0× F5, Inc.). F5, Inc. runs the higher net margin — 18.2% vs 0.5%, a 17.7% gap on every dollar of revenue. On growth, F5, Inc. posted the faster year-over-year revenue change (11.0% vs 7.5%). Over the past eight quarters, F5, Inc.'s revenue compounded faster (8.0% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
F5, Inc. is an American technology company specializing in application security, multi-cloud management, online fraud prevention, application delivery networking (ADN), application availability and performance, and network security, access, and authorization.
ACHC vs FFIV — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $811.7M |
| Net Profit | $4.5M | $148.0M |
| Gross Margin | — | 81.4% |
| Operating Margin | — | 22.1% |
| Net Margin | 0.5% | 18.2% |
| Revenue YoY | 7.5% | 11.0% |
| Net Profit YoY | -50.8% | 1.5% |
| EPS (diluted) | $0.05 | $2.58 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | $811.7M | ||
| Q4 25 | $821.5M | $822.5M | ||
| Q3 25 | $851.6M | $810.1M | ||
| Q2 25 | $869.2M | $780.4M | ||
| Q1 25 | $770.5M | $731.1M | ||
| Q4 24 | $774.2M | $766.5M | ||
| Q3 24 | $815.6M | $746.7M | ||
| Q2 24 | $796.0M | $695.5M |
| Q1 26 | $4.5M | $148.0M | ||
| Q4 25 | $-1.2B | $180.1M | ||
| Q3 25 | $36.2M | $190.5M | ||
| Q2 25 | $30.1M | $189.9M | ||
| Q1 25 | $8.4M | $145.5M | ||
| Q4 24 | $32.6M | $166.4M | ||
| Q3 24 | $68.1M | $165.3M | ||
| Q2 24 | $78.5M | $144.1M |
| Q1 26 | — | 81.4% | ||
| Q4 25 | — | 81.5% | ||
| Q3 25 | — | 82.2% | ||
| Q2 25 | — | 81.0% | ||
| Q1 25 | — | 80.7% | ||
| Q4 24 | — | 81.7% | ||
| Q3 24 | — | 80.8% | ||
| Q2 24 | — | 80.4% |
| Q1 26 | — | 22.1% | ||
| Q4 25 | -142.4% | 26.0% | ||
| Q3 25 | 4.7% | 25.4% | ||
| Q2 25 | 5.8% | 25.2% | ||
| Q1 25 | 1.7% | 21.7% | ||
| Q4 24 | 4.9% | 26.8% | ||
| Q3 24 | 12.1% | 25.6% | ||
| Q2 24 | 13.4% | 23.4% |
| Q1 26 | 0.5% | 18.2% | ||
| Q4 25 | -143.3% | 21.9% | ||
| Q3 25 | 4.3% | 23.5% | ||
| Q2 25 | 3.5% | 24.3% | ||
| Q1 25 | 1.1% | 19.9% | ||
| Q4 24 | 4.2% | 21.7% | ||
| Q3 24 | 8.4% | 22.1% | ||
| Q2 24 | 9.9% | 20.7% |
| Q1 26 | $0.05 | $2.58 | ||
| Q4 25 | $-12.98 | $3.10 | ||
| Q3 25 | $0.40 | $3.25 | ||
| Q2 25 | $0.33 | $3.25 | ||
| Q1 25 | $0.09 | $2.48 | ||
| Q4 24 | $0.36 | $2.82 | ||
| Q3 24 | $0.74 | $2.79 | ||
| Q2 24 | $0.85 | $2.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | $1.4B |
| Total DebtLower is stronger | $2.5B | — |
| Stockholders' EquityBook value | $2.0B | $3.6B |
| Total Assets | $5.5B | $6.5B |
| Debt / EquityLower = less leverage | 1.29× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | $1.4B | ||
| Q4 25 | $133.2M | $1.2B | ||
| Q3 25 | $118.7M | $1.3B | ||
| Q2 25 | $131.4M | $1.4B | ||
| Q1 25 | $91.2M | $1.3B | ||
| Q4 24 | $76.3M | $1.2B | ||
| Q3 24 | $82.1M | $1.1B | ||
| Q2 24 | $77.2M | $935.6M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $2.3B | — | ||
| Q1 25 | $2.2B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $1.9B | — | ||
| Q2 24 | $1.8B | — |
| Q1 26 | $2.0B | $3.6B | ||
| Q4 25 | $1.9B | $3.5B | ||
| Q3 25 | $3.1B | $3.6B | ||
| Q2 25 | $3.1B | $3.5B | ||
| Q1 25 | $3.0B | $3.3B | ||
| Q4 24 | $3.1B | $3.2B | ||
| Q3 24 | $3.0B | $3.1B | ||
| Q2 24 | $3.0B | $3.0B |
| Q1 26 | $5.5B | $6.5B | ||
| Q4 25 | $5.5B | $6.3B | ||
| Q3 25 | $6.4B | $6.3B | ||
| Q2 25 | $6.3B | $6.1B | ||
| Q1 25 | $6.1B | $5.9B | ||
| Q4 24 | $6.0B | $5.9B | ||
| Q3 24 | $5.9B | $5.6B | ||
| Q2 24 | $5.7B | $5.4B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | — | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.74× | — | ||
| Q1 25 | 0.72× | — | ||
| Q4 24 | 0.64× | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.62× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $525.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 13.78× | 3.55× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | $525.1M | ||
| Q4 25 | $-86.3M | $159.2M | ||
| Q3 25 | $73.2M | $208.1M | ||
| Q2 25 | $133.5M | $282.2M | ||
| Q1 25 | $11.5M | $256.6M | ||
| Q4 24 | $116.7M | $202.8M | ||
| Q3 24 | $163.1M | $246.5M | ||
| Q2 24 | $171.1M | $159.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $149.5M | ||
| Q3 25 | $-63.0M | $191.9M | ||
| Q2 25 | $-34.2M | $273.7M | ||
| Q1 25 | $-163.2M | $246.1M | ||
| Q4 24 | $-86.8M | $194.7M | ||
| Q3 24 | $-27.1M | $240.4M | ||
| Q2 24 | $16.9M | $153.1M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 18.2% | ||
| Q3 25 | -7.4% | 23.7% | ||
| Q2 25 | -3.9% | 35.1% | ||
| Q1 25 | -21.2% | 33.7% | ||
| Q4 24 | -11.2% | 25.4% | ||
| Q3 24 | -3.3% | 32.2% | ||
| Q2 24 | 2.1% | 22.0% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 1.2% | ||
| Q3 25 | 16.0% | 2.0% | ||
| Q2 25 | 19.3% | 1.1% | ||
| Q1 25 | 22.7% | 1.4% | ||
| Q4 24 | 26.3% | 1.1% | ||
| Q3 24 | 23.3% | 0.8% | ||
| Q2 24 | 19.4% | 0.8% |
| Q1 26 | 13.78× | 3.55× | ||
| Q4 25 | — | 0.88× | ||
| Q3 25 | 2.02× | 1.09× | ||
| Q2 25 | 4.43× | 1.49× | ||
| Q1 25 | 1.37× | 1.76× | ||
| Q4 24 | 3.58× | 1.22× | ||
| Q3 24 | 2.39× | 1.49× | ||
| Q2 24 | 2.18× | 1.10× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
FFIV
Segment breakdown not available.
